These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15342399)

  • 1. Proteolytic enzymes and altered glycosylation modulate dystroglycan function in carcinoma cells.
    Singh J; Itahana Y; Knight-Krajewski S; Kanagawa M; Campbell KP; Bissell MJ; Muschler J
    Cancer Res; 2004 Sep; 64(17):6152-9. PubMed ID: 15342399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dystroglycan complex in cancer.
    Brennan PA; Jing J; Ethunandan M; Górecki D
    Eur J Surg Oncol; 2004 Aug; 30(6):589-92. PubMed ID: 15256230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression, processing and degradation of dystroglycan in squamous cell carcinomas.
    Jing J; Lien CF; Sharma S; Rice J; Brennan PA; Górecki DC
    Eur J Cancer; 2004 Sep; 40(14):2143-51. PubMed ID: 15341990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular recognition by LARGE is essential for expression of functional dystroglycan.
    Kanagawa M; Saito F; Kunz S; Yoshida-Moriguchi T; Barresi R; Kobayashi YM; Muschler J; Dumanski JP; Michele DE; Oldstone MB; Campbell KP
    Cell; 2004 Jun; 117(7):953-64. PubMed ID: 15210115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies.
    Michele DE; Barresi R; Kanagawa M; Saito F; Cohn RD; Satz JS; Dollar J; Nishino I; Kelley RI; Somer H; Straub V; Mathews KD; Moore SA; Campbell KP
    Nature; 2002 Jul; 418(6896):417-22. PubMed ID: 12140558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fukutin expression in mouse non-muscle somatic organs: its relationship to the hypoglycosylation of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy.
    Saito Y; Yamamoto T; Ohtsuka-Tsurumi E; Oka A; Mizuguchi M; Itoh M; Voit T; Kato Y; Kobayashi M; Saito K; Osawa M
    Brain Dev; 2004 Oct; 26(7):469-79. PubMed ID: 15351084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-dystroglycan interactions affect cerebellar granule neuron migration.
    Qu Q; Smith FI
    J Neurosci Res; 2004 Jun; 76(6):771-82. PubMed ID: 15160389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for dystroglycan in epithelial polarization: loss of function in breast tumor cells.
    Muschler J; Levy D; Boudreau R; Henry M; Campbell K; Bissell MJ
    Cancer Res; 2002 Dec; 62(23):7102-9. PubMed ID: 12460932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced expression of dystroglycan in breast and prostate cancer.
    Henry MD; Cohen MB; Campbell KP
    Hum Pathol; 2001 Aug; 32(8):791-5. PubMed ID: 11521221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dystroglycan and muscular dystrophies related to the dystrophin-glycoprotein complex.
    Sciandra F; Bozzi M; Bianchi M; Pavoni E; Giardina B; Brancaccio A
    Ann Ist Super Sanita; 2003; 39(2):173-81. PubMed ID: 14587215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Processing and secretion of the N-terminal domain of alpha-dystroglycan in cell culture media.
    Saito F; Saito-Arai Y; Nakamura A; Shimizu T; Matsumura K
    FEBS Lett; 2008 Feb; 582(3):439-44. PubMed ID: 18201566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SEA domain proteolysis determines the functional composition of dystroglycan.
    Akhavan A; Crivelli SN; Singh M; Lingappa VR; Muschler JL
    FASEB J; 2008 Feb; 22(2):612-21. PubMed ID: 17905726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional analysis of the N-terminal extracellular region of beta-dystroglycan.
    Di Stasio E; Sciandra F; Maras B; Di Tommaso F; Petrucci TC; Giardina B; Brancaccio A
    Biochem Biophys Res Commun; 1999 Dec; 266(1):274-8. PubMed ID: 10581202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of alternative receptors different than alpha-dystroglycan by selected isolates of lymphocytic choriomeningitis virus.
    Kunz S; Sevilla N; Rojek JM; Oldstone MB
    Virology; 2004 Aug; 325(2):432-45. PubMed ID: 15246281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dystroglycan glycosylation and its role in matrix binding in skeletal muscle.
    Martin PT
    Glycobiology; 2003 Aug; 13(8):55R-66R. PubMed ID: 12736199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression.
    Sgambato A; Migaldi M; Montanari M; Camerini A; Brancaccio A; Rossi G; Cangiano R; Losasso C; Capelli G; Trentini GP; Cittadini A
    Am J Pathol; 2003 Mar; 162(3):849-60. PubMed ID: 12598319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O Mannosylation of alpha-dystroglycan is essential for lymphocytic choriomeningitis virus receptor function.
    Imperiali M; Thoma C; Pavoni E; Brancaccio A; Callewaert N; Oxenius A
    J Virol; 2005 Nov; 79(22):14297-308. PubMed ID: 16254364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A tumor suppressor function of laminin-binding alpha-dystroglycan.
    Bao X; Fukuda M
    Methods Enzymol; 2010; 479():387-96. PubMed ID: 20816178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laminins: structure and genetic regulation.
    Tunggal P; Smyth N; Paulsson M; Ott MC
    Microsc Res Tech; 2000 Nov; 51(3):214-27. PubMed ID: 11054872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Airway epithelial cell wound repair mediated by alpha-dystroglycan.
    White SR; Wojcik KR; Gruenert D; Sun S; Dorscheid DR
    Am J Respir Cell Mol Biol; 2001 Feb; 24(2):179-86. PubMed ID: 11159052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.